Our Approach to Partnering

Collaborating with partners helps bring medical advances to patients

Sunovion Canada is interested in partnering on innovative therapies in the fields of psychiatry, neurology and infectious disease. We are a highly experienced Canadian company with a strong history of partnering for the commercialisation of products in Canada, including regulatory approval, pricing, reimbursement, marketing and sales. We remain very interested in acquiring and licencing additional products for the Canadian marketplace.

Please direct inquiries regarding collaboration and partnership opportunities for the Canadian market to:

• Douglas Reynolds
  President
  Sunovion Pharmaceuticals Canada Inc.
  7025 Langer Drive
  Suite 301
  Mississauga, ON
  L5N 0E8
  Phone: 905-814-9145
  Fax: 905-363-0162